Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone

To report a case evaluating PDT and eplerenone therapy in a patient with bilateral bullous central serous chorioretinopathy. A 30-year-old male was referred for worsening bilateral bullous central serous chorioretinopathy (bCSCR) despite oral eplerenone therapy. Photodynamic therapy (PDT) was perfor...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of ophthalmology case reports Vol. 28; p. 101739
Main Authors Anderson, William J., Smith, Bradley T.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.12.2022
Elsevier
Subjects
Bilateral
Bullous
Case Report
Central serous chorioretinopathy
CSCR
Eplerenone
PDT
CSCR
PDT
Bilateral
Eplerenone
Bullous
Central serous chorioretinopathy
Online AccessGet full text

Cover

More Information
Summary:To report a case evaluating PDT and eplerenone therapy in a patient with bilateral bullous central serous chorioretinopathy. A 30-year-old male was referred for worsening bilateral bullous central serous chorioretinopathy (bCSCR) despite oral eplerenone therapy. Photodynamic therapy (PDT) was performed in the right eye with significant improvement of bullous retinal detachment, near-complete resolution of subfoveal subretinal fluid, and improvement of vision from 20/200 to 20/25. The left eye had persistent subretinal fluid despite continued eplerenone therapy. Neither eye worsened when eplerenone was withdrawn. Total follow up was 3.5 years. This case demonstrates a significant and durable effect of PDT in bullous CSCR and suggests a lack of response to eplerenone.
ISSN:2451-9936
2451-9936
DOI:10.1016/j.ajoc.2022.101739